Psychiatry, Randomized controlled trial, Clinical psychology, Psychological intervention and Mental health are her primary areas of study. Psychiatry is a component of her Substance abuse, Motivational interviewing, Cannabis, Cognitive therapy and Psychiatric hospital studies. Her Randomized controlled trial research is multidisciplinary, relying on both Nicotine replacement therapy, Prevalence of mental disorders, Distress and Public health.
She has researched Clinical psychology in several fields, including Meta-analysis, Epidemiology, Depression and Comorbidity. Her research in Psychological intervention intersects with topics in Relapse prevention and Methadone maintenance. Amanda L. Baker has included themes like Environmental health, Suicide prevention and Anxiety in her Mental health study.
Her primary areas of investigation include Psychiatry, Clinical psychology, Psychological intervention, Mental health and Randomized controlled trial. Her Depression, Comorbidity, Motivational interviewing, Substance abuse and Cannabis study are her primary interests in Psychiatry. Her study in Clinical psychology is interdisciplinary in nature, drawing from both Schizophrenia, Psychosis, Cognitive therapy, Cognition and Brief intervention.
Her work carried out in the field of Psychological intervention brings together such families of science as Psychosocial, Alcohol dependence and Family medicine. Her Mental health research incorporates themes from Nursing, Drug, Substance use and Anxiety. Her studies deal with areas such as Intervention, Physical therapy, Clinical trial and Abstinence as well as Randomized controlled trial.
Her scientific interests lie mostly in Psychological intervention, Randomized controlled trial, Mental health, Intervention and Clinical psychology. Her Psychological intervention research is within the category of Psychiatry. Her study in the fields of Comorbidity, Psychosis, Psychosocial and Methamphetamine under the domain of Psychiatry overlaps with other disciplines such as Context.
In her study, which falls under the umbrella issue of Randomized controlled trial, Clinical trial, Meta-analysis and Cognitive behavioral therapy is strongly linked to Physical therapy. Her work on Mental illness as part of general Mental health research is frequently linked to Focus group, thereby connecting diverse disciplines of science. Her work deals with themes such as Cognition, Loneliness and Depression, which intersect with Clinical psychology.
Amanda L. Baker focuses on Psychological intervention, Randomized controlled trial, Psychiatry, Addiction and Mental health. Amanda L. Baker combines subjects such as Physical therapy, Depression, Gerontology and Family medicine with her study of Psychological intervention. Her study focuses on the intersection of Randomized controlled trial and fields such as Intervention with connections in the field of Behavior change, Psychological treatment and Systematic review.
She performs multidisciplinary study on Psychiatry and Attendance in her works. Her research integrates issues of Cognition and Clinical psychology in her study of Addiction. Her research investigates the connection between Mental health and topics such as Abstinence that intersect with problems in CINAHL and Scopus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients: I. Outcome.
Nicholas Tarrier;Richard Beckett;Sue Harwood;Amanda Baker.
British Journal of Psychiatry (1993)
An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R)
Simon J. Adamson;Frances J. Kay-Lambkin;Amanda L. Baker;Terry J. Lewin.
Drug and Alcohol Dependence (2010)
Integrated Exposure-Based Therapy for Co-occurring Posttraumatic Stress Disorder and Substance Dependence: A Randomized Controlled Trial
Katherine L. Mills;Maree Teesson;Sudie E. Back;Kathleen T. Brady.
Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy
Frances J. Kay‐Lambkin;Amanda L. Baker;Terry J. Lewin;Vaughan J. Carr.
A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder
Amanda Baker;Robyn Richmond;Melanie Haile;Terry J. Lewin.
American Journal of Psychiatry (2006)
A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
Sarah A. Hiles;Amanda L. Baker;Theo de Malmanche;John Attia;John Attia.
Brain Behavior and Immunity (2012)
Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction
Amanda Baker;Nicole K. Lee;Melissa Claire;Terry J. Lewin.
Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
Rebecca McKetin;Dan I. Lubman;Amanda L. Baker;Sharon Dawe.
JAMA Psychiatry (2013)
Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis.
S. A. Hiles;A. L. Baker;T. de Malmanche;J. Attia.
Psychological Medicine (2012)
Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study
Rebecca McKetin;Dan I. Lubman;Jake M. Najman;Sharon Dawe.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: